Abstract:Abstract Background Intestinal homeostasis depends on complex interactions between the microbiota, the intestinal epithelium and the host immune system. Paneth cells play an important role thanks to their release of antimicrobial peptides and their dysfunction has been shown to contribute to Crohn’s disease. The human gut commensal Bifidobacteria has been highlighted as a protective agent in IBD. Whilst the specific modulating factors are largely unidentified, evidence suggests that Bifidobacteria can interact with host intestinal cells. Such interactions can alter host molecular pathways, resulting in a modified intestinal cell function. Understanding these effects is crucial to unravel the potential benefits of bifidobacteria for IBD. In this study, we developed a workflow to investigate the beneficial effects of the probiotic bifidobacteria in modulating gene regulation and function of different intestinal epithelial cells in the gut. Methods We gavaged either conventionally raised (SPF) or germ-free mice (n = 5) with Bifidobacterium breve UCC2003 (1–5 × 108 CFU), and sorted intestinal epithelial cell types (Lgr5+ stem cells, Paneth cells and transit-amplifying cells) from the mouse intestinal tissue by flow cytometry using a panel of known antibodies. Each isolated cell population (n = 200) was subsequently profiled by low input RNA sequencing and DNA methylation. Results Intracellular lysozyme staining for Paneth cells and initial gene expression data exploration suggests successful separation of the different populations from the mouse intestinal tissue using flow cytometry. Gene expression data were further analysed using network biology approaches to generate cell-type-specific molecular regulatory networks indicating genes regulation by bifidobacteria in each cell types. Overlaying the methylation data will elucidate the role of epigenetics played during this regulation. Together, these networks will improve our understanding of how Bifidobacteria affects these different cells types through communication with precursor stem cells and/or with direct effects on the fully differentiated cells, ultimately impacting their function. Conclusion In the future, we aim to use a similar workflow using two-dimensional human-derived organoids monolayers co-cultured with bifidobacteria to investigate the effects on host intestinal epithelial cell function in a high-throughput and patient-specific manner. This will increase our understanding of the complex role played by host genetics and microbial factors in the pathogenesis of gastrointestinal diseases such as IBD, and hopefully pave the way for translational developments in the prevention these pathologies.

Multiomics analysis reveals the biological effects of live Roseburia intestinalis as a high‐butyrate‐producing bacterium in human intestinal epithelial cells

Assessment of the safety and probiotic properties of <i>Roseburia intestinalis</i>: A potential "Next Generation Probiotic"

Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species

Isolation and characterisation of new putative probiotic bacteria from human colonic flora

The Probiotic and Immunomodulation Effects of Limosilactobacillus Reuteri RGW1 Isolated from Calf Feces

Human Gut Symbiont Roseburia hominis Promotes and Regulates Innate Immunity

Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics

Roseburia hominis Alleviates Neuroinflammation via Short-Chain Fatty Acids through Histone Deacetylase Inhibition

The Probiotic Strain Bifidobacterium animalis ssp. lactis HY8002 Potentially Improves the Mucosal Integrity of an Altered Intestinal Microbial Environment

Physiological activity of E. coli engineered to produce butyric acid

Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model

Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Widely targeted metabolomics-based analysis of the impact of L. plantarum and L. paracasei fermentation on rosa roxburghii Tratt juice

Cross-Feeding and Enzymatic Catabolism for Mannan-Oligosaccharide Utilization by the Butyrate-Producing Gut Bacterium Roseburia hominis A2-183

Multifunctional Probiotic and Functional Properties of Lactiplantibacillus plantarum LRCC5314, Isolated from Kimchi

Lactiplantibacillusplantarum APsulloc331261 (GTB1TM) promotes butyrate production to suppress mucin hypersecretion in a murine allergic airway inflammation model

Isolation and identification of mucin-degrading bacteria originated from human faeces and their potential probiotic efficacy according to host-microbiome enterotype

L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human

In vivo Trial of Bifidobacterium longum Revealed the Complex Network Correlations Between Gut Microbiota and Health Promotional Effects

P071 Studying the effects of the probiotic bifidobacteria on gut health and intestinal epithelial cells function

Black raspberry extract shifted gut microbe diversity and their metabolic landscape in a human colonic model